V
VOR
Vor Biopharma Inc.
25.10
+0.05+0.20%After Hours: 25.01 -0.09 -0.36%17:31 09/08 EDT
OPEN/PREV CLOSE24.75/25.05
TODAY RANGE24.10-26.00
VOL856.38K
MARKET CAP1.48B
52 WEEK RANGE6.50-49.95
AVG VOL (3M)1.15M
% TURNOVER1.45%
TURNOVER--
P/E (TTM)-0.5837
% RANGE7.58%
EPS(TTM)-43.0024
P/E(FORWARD)-3.4793
P/B-6.8275
BVPS-3.6763
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.29B
SHARES OUTSTANDING59.16M
NEXT EARNINGS11/11-11/16
FREE FLOAT51.21M
LOT SIZE1
EX-DATE09/19/2025
News
Press Releases
Financial Reports
Profile
TipRanks·10h ago
Vor Bio completes enrollment in UPSTREAM MG trial
TipRanks·4d ago
Vor Bio files automatic mixed securities shelf
Simply Wall St·09/01 10:18
Vor Biopharma (VOR), What Is Drawing Fresh Attention Now?
Simply Wall St·08/25 03:25
Why Did Vor Biopharma (VOR) Stock Drop After Its Latest Update?
Simply Wall St·08/17 22:22
How Investors Are Reacting To Vor Biopharma (VOR) Sharply Narrowed Losses And Earnings Profile Shift
Simply Wall St·08/14 06:33
Why Did Vor Biopharma (VOR) Shares Climb After Its Latest Update?
TipRanks·08/13 15:55
Citi Remains a Buy on Vor Biopharma (VOR)
Simply Wall St·08/13 03:33
Vor Biopharma (VOR) Stock Looks Reasonable On Earnings Yet Weak On Broader Checks
Dow Jones·08/12 16:15
Vor Biopharma Price Target Raised to $27.00/Share From $18.00 by Wedbush
Dow Jones·08/12 16:15
Vor Biopharma Is Maintained at Neutral by Wedbush
Benzinga·08/12 16:05
Wedbush Maintains Neutral on Vor Biopharma, Raises Price Target to $27
TipRanks·08/12 13:55
Vor Biopharma (VOR) Receives a Hold from Wedbush
TipRanks·08/12 10:58
Wells Fargo Issues a Buy Rating on Vor Biopharma (VOR)
Same Industry
Name/Symbol
Change%
Price